Although the female gender is generally less represented in cardiovascular studies, observational and randomized investigations suggest that-compared with men-women may obtain different benefits from antiplatelet therapy. Multiple factors, including hormonal mechanisms and differences in platelet biology, might contribute to such apparent gender peculiarities. The thrombotic and bleeding risks, as well as outcomes after a cardiovascular event, appear to differ between genders, partly in relation to differences in age, comorbidities and body size. Equally, the benefits of antiplatelet therapy may differ in women compared with men in different vascular beds, during primary or secondary prevention and according to the type of an antiplatelet agent used. This document is an attempt to bring together current evidence, clinical practices and gaps of knowledge on gender-specific platelet function and antiplatelet therapy. On the basis of the available data, we provide suggestions on current indications of antiplatelet therapy for cardiovascular prevention in women with different clinical features; no strong recommendation may be given because the available data derive from observational studies or post hoc/subgroup analyses of randomized studies without systematic adjustments for baseline risk profiles. Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014. For permissions please email: journals.permissions@oup.com.

Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper / Giuseppe, Patti; R., De Caterina; R., Abbate; F., Andreotti; L. M., Biasucci; P., Calabro; G., Cioni; G., Davi; G., Di Sciascio; E., Golia; P., Golino; G., Malatesta; F., Mangiacapra; R., Marcucci; A., Nusca; V. M., Parato; V., Pengo; D., Prisco; Pulcinelli, FABIO MARIA; G., Renda; E., Ricottini; B., Ruggieri; F., Santilli; F., Sofi; M., Zimarino; O. F., Cardiology Working Group On Thrombosis Of The Italian Society. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - STAMPA. - 35:33(2014), pp. 2213-2223. [10.1093/eurheartj/ehu279]

Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper.

PULCINELLI, FABIO MARIA;
2014

Abstract

Although the female gender is generally less represented in cardiovascular studies, observational and randomized investigations suggest that-compared with men-women may obtain different benefits from antiplatelet therapy. Multiple factors, including hormonal mechanisms and differences in platelet biology, might contribute to such apparent gender peculiarities. The thrombotic and bleeding risks, as well as outcomes after a cardiovascular event, appear to differ between genders, partly in relation to differences in age, comorbidities and body size. Equally, the benefits of antiplatelet therapy may differ in women compared with men in different vascular beds, during primary or secondary prevention and according to the type of an antiplatelet agent used. This document is an attempt to bring together current evidence, clinical practices and gaps of knowledge on gender-specific platelet function and antiplatelet therapy. On the basis of the available data, we provide suggestions on current indications of antiplatelet therapy for cardiovascular prevention in women with different clinical features; no strong recommendation may be given because the available data derive from observational studies or post hoc/subgroup analyses of randomized studies without systematic adjustments for baseline risk profiles. Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014. For permissions please email: journals.permissions@oup.com.
2014
gender differences; platelets; antiplatelet therapy; men; thrombosis; women
01 Pubblicazione su rivista::01a Articolo in rivista
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper / Giuseppe, Patti; R., De Caterina; R., Abbate; F., Andreotti; L. M., Biasucci; P., Calabro; G., Cioni; G., Davi; G., Di Sciascio; E., Golia; P., Golino; G., Malatesta; F., Mangiacapra; R., Marcucci; A., Nusca; V. M., Parato; V., Pengo; D., Prisco; Pulcinelli, FABIO MARIA; G., Renda; E., Ricottini; B., Ruggieri; F., Santilli; F., Sofi; M., Zimarino; O. F., Cardiology Working Group On Thrombosis Of The Italian Society. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - STAMPA. - 35:33(2014), pp. 2213-2223. [10.1093/eurheartj/ehu279]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/629274
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 80
  • ???jsp.display-item.citation.isi??? 69
social impact